ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIRO..CY..TRBGCZEEHUPLSK....IS..............................*JJDIM360 Ver 1.28 (29 Oct 2014) - 2999001/0The file contains technical information submitted after the application was filed and not included in this specification1940373CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120150624W174deBibliographieenBibliographyfrBibliographieEP06850456.2200610132008051220120131enenen725634 P20051013US2015062420152620080709200828201505062015192014112620150624201526A61K 31/045 20060101AFI20090423BHEP A61K 31/047 20060101ALI20090423BHEP A61K 31/075 20060101ALI20090423BHEP A61P 25/28 20060101ALI20090423BHEP de1-FLUORO-1-DEOXY-SCYLLO-INOSITOL ZUR BEHANDLUNG VON ALZHEIMER'SCHE KRANKHEITen1-FLUORO-1-DEOXY-SCYLLO-INOSITOL FOR THE TREATMENT OF ALZHEIMER'S DISEASEfr1-FLUORO-1-DEOXY-SCYLLO-INOSITOL DESTINE AU TRAITEMENT DE LA MALADIE D'ALZHEIMERWO-A-2007/041855WO-A-2007/134449WO-A1-2004/075882WO-A1-2006/053428CA-A1- 2 214 635CA-A1- 2 486 663SUN Y ET AL: "Synthesis of scyllo-inositol derivatives and their effects on amyloid beta peptide aggregation", BIOORGANIC & MEDICINAL CHEMISTRY, PERGAMON, GB, vol. 16, no. 15, 1 August 2008 (2008-08-01), pages 7177-7184, XP023610694, ISSN: 0968-0896, DOI: 10.1016/J.BMC.2008.06.045 [retrieved on 2008-06-26]20090429CRUZ, Antonio89 Dunloe RoadToronto, Ontario M5P 2T7CAKURDYDYK, Linda215 St. ClementsToronto, Ontario M4R 1H3CAWaratah Pharmaceuticals, Inc.100997913P033331EP CTH101 College Street Suite 220Toronto, ON M5G 1L7CAHarding, Charles Thomaset al100033481D Young & Co LLP 120 HolbornLondon EC1N 2DYGBATBEBGCHCYCZDEDKEEESFIFRGBGRHUIEISITLILTLULVMCNLPLPTROSESISKTRIB200600418120061013enWO200711910820071025200743